Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Journal of Vascular Surgery
|
February 26, 2024
Changes in global mortality from aortic aneurysm
Brianna M Krafcik, David H Stone, Ming Cai, et al.
Archives of Internal Medicine
|
July 14, 2004
Management of alcohol withdrawal delirium. An evidence-based practice guideline
Michael F Mayo-Smith, Lee H Beecher, Timothy L Fischer, et al.
Mabs
|
February 5, 2014
Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
Kathleen R Whiteman, Holly A Johnson, Michele F Mayo, et al.
Blood
|
September 5, 2013
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
Jutta Deckert, Peter U Park, Sharon Chicklas, et al.
International Journal of Molecular Sciences
|
April 14, 2026
Is Neoadjuvancy with Imatinib Useful Before Mohs Surgery in Locally Advanced Dermatofibrosarcoma Protuberans? Experience of a Dermato-Oncology Referral Center
A Bota-Llorca, B Llombart-Cussac, C Serra-Guillén, et al.
Bioorganic & Medicinal Chemistry
|
February 6, 2018
Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4
Sébastien L Degorce, Rana Anjum, Keith S Dillman, et al.
Journal of Medicinal Chemistry
|
October 18, 2019
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88<sup>L265P</sup> Mutant Diffuse Large B Cell Lymphoma
Sébastien L Degorce, Rana Anjum, Andrew Bloecher, et al.
Molecular Cancer Therapeutics
|
May 25, 2016
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Michael L Miller, Nathan E Fishkin, Wei Li, et al.
Cancer Research
|
March 4, 2010
Antibody-maytansinoid conjugates designed to bypass multidrug resistance
Yelena V Kovtun, Charlene A Audette, Michele F Mayo, et al.
The Annals of Pharmacotherapy
|
April 4, 2017
Results of a Regional Effort to Improve Warfarin Management
Adam J Rose, Angela Park, Christopher Gillespie, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Journal of Vascular Surgery
|
February 26, 2024
Changes in global mortality from aortic aneurysm
Brianna M Krafcik, David H Stone, Ming Cai, et al.
Archives of Internal Medicine
|
July 14, 2004
Management of alcohol withdrawal delirium. An evidence-based practice guideline
Michael F Mayo-Smith, Lee H Beecher, Timothy L Fischer, et al.
Mabs
|
February 5, 2014
Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models
Kathleen R Whiteman, Holly A Johnson, Michele F Mayo, et al.
Blood
|
September 5, 2013
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies
Jutta Deckert, Peter U Park, Sharon Chicklas, et al.
International Journal of Molecular Sciences
|
April 14, 2026
Is Neoadjuvancy with Imatinib Useful Before Mohs Surgery in Locally Advanced Dermatofibrosarcoma Protuberans? Experience of a Dermato-Oncology Referral Center
A Bota-Llorca, B Llombart-Cussac, C Serra-Guillén, et al.
Bioorganic & Medicinal Chemistry
|
February 6, 2018
Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4
Sébastien L Degorce, Rana Anjum, Keith S Dillman, et al.
Journal of Medicinal Chemistry
|
October 18, 2019
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88<sup>L265P</sup> Mutant Diffuse Large B Cell Lymphoma
Sébastien L Degorce, Rana Anjum, Andrew Bloecher, et al.
Molecular Cancer Therapeutics
|
May 25, 2016
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating Activity
Michael L Miller, Nathan E Fishkin, Wei Li, et al.
Cancer Research
|
March 4, 2010
Antibody-maytansinoid conjugates designed to bypass multidrug resistance
Yelena V Kovtun, Charlene A Audette, Michele F Mayo, et al.
The Annals of Pharmacotherapy
|
April 4, 2017
Results of a Regional Effort to Improve Warfarin Management
Adam J Rose, Angela Park, Christopher Gillespie, et al.
Page
of 8